… Endocrine Society’s annual meeting (ENDO 2025) on Sunday, July … which will be presented during ENDO 2025. These data include composite … of Amylyx’ presentations at ENDO 2025 are as follows: … and related comments in our earnings conference call speak only …

… chief commercial officer of Endo's branded pharmaceuticals … leadership roles at Biogen, Endo, Collegium Pharmaceutical and more. … sales. In its first-quarter earnings report (PDF) last month … about the first-quarter earnings, Crossley said the marketing …

… NASDAQ:CRNX) Q1 2025 Earnings Call Transcript May 8, … Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is … by academic endocrinologists, like Endo, and by community endocrinologists … in my first earnings call at Crinetics Pharmaceuticals …

… 2025 Henry Schein, Inc. beats earnings expectations. Reported EPS is $1 … heading and in our quarterly earnings presentation also posted on … digit to low double-digit earnings growth by continuing to … is very small and some endo, we are making in the …

… Ascendis Pharma First Quarter 2025 Earnings Conference Call. At this time … because we are seeing and endo in a very, very, very … control patients that see the endo on much, much less frequent … the patient that sees the endo and high frequency. And I …

… , 2025 Lazard Ltd beats earnings expectations. Reported EPS is … is provided in our earnings release and investor presentation. … $6.7 billion combination with Endo Pharmaceuticals, Sun Communities’ $5.7 … ’s first quarter 2025 earnings conference call. Again, …

… 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0 … expect to offset the associated earnings per share dilution through … and some ICTX and some endo. So a lot of VBP … And breaking it down, the Endo team continues to deliver at …

… .A. (NASDAQ:EDAP) Q4 2024 Earnings Call Transcript March 27, 2025 … EDAP TMS S.A. beats earnings expectations. Reported EPS is $-0 … Quarter and Full Year 2024 Earnings Conference Call. At this time … 60 consecutive patients from the Endo-HIFU-R1 Phase 2 study …

… Eton Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS … statements disclaimer in our earnings release and the risk … conferences. With PES, PENDS, ENDO, NAAP. Peer-to-peer … reporting adjusted non-GAAP earnings results. This is intended …

… Month, we have launched the Endo the Battle campaign, to … experienced a significant decrease in earnings, which makes funding private care … but also the loss of earnings. I had my own business … Dometriosis, as well as founding Endo Education. When asked what …